Alcohol Damages the Brain's Own GLP-1 System, Suggesting Incretin Drugs Could Help
Alcohol use disorder is associated with reduced GLP-1, GIP, leptin, and ghrelin expression in the frontal lobe, suggesting that GLP-1 receptor agonists could help restore brain energy metabolism and cognitive function.
Quick Facts
What This Study Found
AUD reduced GLP-1, GIP, leptin, and ghrelin immunoreactivity in the frontal lobe, while pancreatic polypeptide was reduced in the cerebellar vermis, alongside increased neurodegeneration marker NfL in both regions.
Key Numbers
How They Did This
Postmortem study comparing cerebellar vermis and anterior frontal lobe tissue from 6 adult male AUD donors and 6 controls using duplex and multiplex ELISAs for NfL and gut hormone panel.
Why This Research Matters
If alcohol damages the brain's incretin system, GLP-1 drugs could potentially treat not just the addiction aspects of AUD but also the cognitive and neurobehavioral deficits that make recovery so difficult.
The Bigger Picture
This connects the burgeoning field of GLP-1 therapy for addiction with a mechanistic explanation: alcohol literally depletes the brain's incretin signaling, and GLP-1 drugs could replenish it.
What This Study Doesn't Tell Us
Very small sample size (6 per group). Male subjects only. Postmortem tissue analysis cannot determine causality or temporal relationships. Cannot distinguish effects of alcohol from effects of nutritional deficiency common in AUD.
Questions This Raises
- ?Would GLP-1 receptor agonists restore frontal lobe incretin signaling and improve cognition in living AUD patients?
- ?Are the brain incretin changes reversible with sobriety alone, or do they require pharmacological intervention?
- ?Do females with AUD show the same pattern of brain incretin depletion?
Trust & Context
- Key Stat:
- Depleted brain GLP-1 The frontal lobe showed reduced GLP-1, GIP, leptin, and ghrelin in people with alcohol use disorder
- Evidence Grade:
- Small postmortem study (n=12 total) providing mechanistic insight. Novel finding but very limited sample size requires replication.
- Study Age:
- Published in 2025, providing the first human evidence of brain incretin depletion in alcohol-related brain damage.
- Original Title:
- Impaired Brain Incretin and Gut Hormone Expression in Human Alcohol-Related Brain Damage: Opportunities for Therapeutic Targeting.
- Published In:
- Biomolecules, 16(1) (2026)
- Database ID:
- RPEP-15086
Evidence Hierarchy
Frequently Asked Questions
Does alcohol damage the brain's metabolic signaling?
Yes. This study found that chronic alcohol abuse depletes important signaling molecules including GLP-1 and GIP in the brain's frontal lobe, which likely contributes to the cognitive problems seen in alcohol-related brain damage.
Could GLP-1 drugs help people recover from alcohol brain damage?
The findings suggest this is plausible—by restoring depleted incretin signaling in the brain. However, this has not yet been tested in clinical trials and remains a hypothesis that needs further research.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15086APA
de la Monte, Suzanne M; Tong, Ming; Carlson, Rolf I; Sutherland, Greg. (2026). Impaired Brain Incretin and Gut Hormone Expression in Human Alcohol-Related Brain Damage: Opportunities for Therapeutic Targeting.. Biomolecules, 16(1). https://doi.org/10.3390/biom16010099
MLA
de la Monte, Suzanne M, et al. "Impaired Brain Incretin and Gut Hormone Expression in Human Alcohol-Related Brain Damage: Opportunities for Therapeutic Targeting.." Biomolecules, 2026. https://doi.org/10.3390/biom16010099
RethinkPeptides
RethinkPeptides Research Database. "Impaired Brain Incretin and Gut Hormone Expression in Human ..." RPEP-15086. Retrieved from https://rethinkpeptides.com/research/de-2026-impaired-brain-incretin-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.